000705.SZ
浙江震元
SZSE · Healthcare · F 批发零售 · CN
CNY 6.93
−1.56%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.0B | 2.3B | 3.7B | 4.1B | 4.1B |
| Cost of Revenue | 1.5B | 1.7B | 3.0B | 3.3B | 3.4B |
| Gross Profit | 493.4M | 567.5M | 703.7M | 767.2M | 754.5M |
| Operating Expenses | |||||
| R&D Expense | 47.4M | 48.8M | 55.6M | 46.2M | 43.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 142.9M | 146.3M | 176.0M | 146.6M | 147.3M |
| Selling & Marketing Expense | 311.1M | 346.0M | 408.3M | 464.7M | 441.1M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 519.6M | 558.2M | 658.3M | 667.8M | 647.2M |
| Cost and Expenses | 2.0B | 2.3B | 3.7B | 4.0B | 4.0B |
| Operating Income (EBIT) | (19.4M) | 37.8M | 55.9M | 113.0M | 105.3M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (21.5M) | 36.2M | 53.6M | 110.2M | 102.5M |
| Income Tax Expense | 13.5M | 13.5M | 17.4M | 25.2M | 20.6M |
| Bottom Line | |||||
| Net Income | (35.0M) | 22.7M | 34.7M | 81.6M | 77.9M |
| Earnings from Cont. Ops | (35.0M) | 22.7M | 36.2M | 85.0M | 81.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (35.0M) | 22.7M | 34.7M | 81.6M | 77.9M |
| Per Share | |||||
| Basic EPS | (CN¥0.10) | CN¥0.07 | CN¥0.10 | CN¥0.24 | CN¥0.23 |
| Diluted EPS | (CN¥0.10) | CN¥0.07 | CN¥0.10 | CN¥0.24 | CN¥0.23 |
| Revenue Per Share | CN¥5.88 | CN¥7.02 | CN¥10.77 | CN¥12.07 | CN¥12.24 |
| Shares | |||||
| Basic Shares Outstanding | 334.0M | 324.2M | 347.3M | 340.2M | 338.7M |
| Diluted Shares Outstanding | 334.0M | 324.2M | 347.3M | 340.2M | 338.7M |
| Profitability Metrics | |||||
| EBITDA | — | 114.5M | 132.9M | 182.5M | 172.5M |
| D&A | — | 76.7M | 77.0M | 69.5M | 67.1M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026